Home › Funds › Patient Square Capital LP › ARGX

Patient Square Capital LP position in ARGX

Argenx S.E. · Health Care

Patient Square Capital LP reported holding 28,000 shares of ARGX (Argenx S.E.) in its Q3 2026 13F filing — a position valued at US$26.8M, representing 4.28% of its reported portfolio and ranking #4 among its reported holdings. Patient Square Capital LP has disclosed ARGX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)28.00K sh
Reported value held$26.85M
Portfolio Weight4.28%
First reportedQ2 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's ARGX position evolved

Patient Square Capital LP first disclosed a stake in ARGX in Q2 2025 at 29,000 shares (US$16.0M). The position peaked in Q3 2026 at 28,000 shares, worth US$26.8M. Across 6 filings, Patient Square Capital LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 28,000 shares valued at US$26.8M — an increase of 5,000 shares quarter over quarter.. Notable position changes include a 47% trim in Q3 2025 (shares rose 14% over the following quarter), a 68% increase in Q4 2025 (shares fell 13% over the following quarter), a 41% increase in Q1 2026 (shares rose 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 29.00K $15.99M New
Q3 2025 15.50K $11.43M Reduce
Q4 2025 26.00K $21.86M Add
Q1 2026 36.72K $26.81M Add
Q2 2026 23.00K $21.34M Reduce
Q3 2026 28.00K $26.85M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARGX and 13F data

ARGX (Argenx S.E.) is a Health Care company. 36 other funds we track also report a position in ARGX — the largest reported positions include Jupiter Topco LLC (US$2.30B), Janus Henderson Group (US$1.85B), Artisan Partners Limited Partnership (US$1.12B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARGX

All ARGX fund holders →

FAQ

How long has Patient Square Capital LP held ARGX?

Patient Square Capital LP has disclosed ARGX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Patient Square Capital LP's current position in ARGX?

As of Q3 2026, Patient Square Capital LP holds 28.00K shares of ARGX (Argenx S.E.), valued at $26.85M, representing 4.28% of its reported portfolio and ranking #4.

Has Patient Square Capital LP been buying or selling ARGX?

In the latest 13F filing (Q3 2026), Patient Square Capital LP increased its position in ARGX. The position peaked in Q3 2026 at 28.00K shares.

Which other funds hold ARGX?

Other major institutional holders of ARGX include Jupiter Topco LLC, Janus Henderson Group, Artisan Partners Limited Partnership, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.